Gutierrez, C.L.D. et al. 2026. High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. Journal of Medical Cases. 17, 4 (Jan. 2026), 146–152. DOI:https://doi.org/10.14740/jmc5237.